BRIEF published on 09/23/2026 at 07:35, 1 month 8 days ago Sensorion Reports 2026 Half-Year Results and Updates Financial Results Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 09/23/2026 at 07:35, 1 month 8 days ago Sensorion publie ses résultats et mises à jour du premier semestre 2026 Résultats Financiers Thérapie Génique Sensorion Perte Auditive SENS-601
PRESS RELEASE published on 09/23/2026 at 07:30, 1 month 8 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats semestriels 2026. Annonce des avancées sur SENS-601, programme de thérapie génique pour la perte auditive. Prévision d'administration au premier patient début 2027 Thérapie Génique Sensorion Perte Auditive SENS-601 Résultats Semestriels 2026
PRESS RELEASE published on 09/23/2026 at 07:30, 1 month 8 days ago Inside Information / News release on accounts, results Sensorion reports 2026 half-year results, provides corporate update, and announces availability of the half-year report. Progress on gene therapy programs showcased Financial Highlights Gene Therapy Clinical Trial Sensorion 2026 Results
BRIEF published on 09/18/2026 at 07:35, 1 month 13 days ago Sensorion dévoile les détails du SENS-601 Program Day Thérapie Génique Sensorion Perte Auditive SENS-601 HearConnex
BRIEF published on 09/18/2026 at 07:35, 1 month 13 days ago Sensorion unveils details of the SENS-601 Program Day Gene Therapy Hearing Loss SENS-601 Sensory HearConnex
PRESS RELEASE published on 09/18/2026 at 07:30, 1 month 13 days ago Informations privilégiées / Autres communiqués Sensorion annonce les modalités de connexion pour son SENS-601 Program Day du 22 septembre 2026, détaillant les conférenciers et l'accès à l'événement en ligne Thérapie Génique Sensorion Perte Auditive Connexion SENS-601 Program Day
PRESS RELEASE published on 09/18/2026 at 07:30, 1 month 13 days ago Inside Information / Other news releases Sensorion announces connection details for its SENS-601 Program Day on September 22, 2026, featuring Prof. Christine Petit and Dr. Sharon Cushing. Details available on the Company's website Gene Therapy Sensorion SENS-601 Program Day Connection Details
BRIEF published on 09/16/2026 at 07:35, 1 month 15 days ago Sensorion envisage une introduction en bourse aux États-Unis Biotechnologie SEC Introduction En Bourse Sensorion Thérapies Auditives
BRIEF published on 09/16/2026 at 07:35, 1 month 15 days ago Sensorion is considering an initial public offering in the United States Biotechnology Initial Public Offering DRY Sensory Auditory Therapies
Published on 10/30/2026 at 23:35, 1 day 23 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 23 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 3 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 7 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 12 hours 20 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 17 hours 55 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 6 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 23 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 23 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
